Isabel Madueno-Ortega

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Apolipoprotein E proteotyping as a valid alternative to genotyping in clinical practice.

Apolipoprotein E proteotyping as a valid alternative to genotyping in clinical practice.

Journal: Journal of Alzheimer's disease : JAD

Published: April 06, 2026

Differential distribution of antiviral serology across multiple sclerosis phenotypes and its implications for disease pathogenesis.

Differential distribution of antiviral serology across multiple sclerosis phenotypes and its implications for disease pathogenesis.

Journal: Scientific reports

Published: January 12, 2026

Differential distribution of antiviral serology across multiple sclerosis phenotypes and its implications for disease pathogenesis.

Differential distribution of antiviral serology across multiple sclerosis phenotypes and its implications for disease pathogenesis.

Journal: Scientific reports

Published: January 12, 2026

Impact of blood p-tau217 testing on diagnosis and diagnostic confidence in cognitive disorders: a real-world clinical study.

Impact of blood p-tau217 testing on diagnosis and diagnostic confidence in cognitive disorders: a real-world clinical study.

Journal: Journal of neurology

Published: October 19, 2025

Unexpected Falsely High Vancomycin Concentrations in a Patient with Endocarditis During Routine Therapeutic Drug Monitoring.

Unexpected Falsely High Vancomycin Concentrations in a Patient with Endocarditis During Routine Therapeutic Drug Monitoring.

Journal: European journal of case reports in internal medicine

Published: April 27, 2025

Detection of cerebrospinal fluid biomarkers changes of Alzheimer's disease using a cognitive stress test in persons with subjective cognitive decline and mild cognitive impairment.

Detection of cerebrospinal fluid biomarkers changes of Alzheimer's disease using a cognitive stress test in persons with subjective cognitive decline and mild cognitive impairment.

Journal: Frontiers in psychology

Published: January 19, 2024

A data-driven approach to complement the A/T/(N) classification system using CSF biomarkers.

A data-driven approach to complement the A/T/(N) classification system using CSF biomarkers.

Journal: CNS neuroscience & therapeutics

Published: April 26, 2023

Integration of Multiple Interferometers in Highly Multiplexed Diagnostic KITs to Evaluate Several Biomarkers of COVID-19 in Serum.

Integration of Multiple Interferometers in Highly Multiplexed Diagnostic KITs to Evaluate Several Biomarkers of COVID-19 in Serum.

Journal: Biosensors

Published: July 22, 2022

"Brain Fog" by COVID-19 or Alzheimer's Disease? A Case Report.

"Brain Fog" by COVID-19 or Alzheimer's Disease? A Case Report.

Journal: Frontiers in psychology

Published: June 11, 2021

Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls.

Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls.

Journal: Cells

Published: November 29, 2020

Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab.

Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab.

Journal: Scientific reports

Published: February 12, 2020

Syncytin-1/HERV-W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients.

Syncytin-1/HERV-W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients.

Journal: European journal of immunology

Published: September 26, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026